(Q42521987)

English

Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies (English)

1 reference

Europe PubMed Central

1 November 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

Michele T. Yip-Schneider

2

1 reference

Europe PubMed Central

1 November 2017

author name string

Bryan Holcomb

1

1 reference

Europe PubMed Central

1 November 2017

Jesus M Matos

3

1 reference

Europe PubMed Central

1 November 2017

Jennifer Dixon

4

1 reference

Europe PubMed Central

1 November 2017

Jason Kennard

5

1 reference

Europe PubMed Central

1 November 2017

Julie Mahomed

6

1 reference

Europe PubMed Central

1 November 2017

Rajasubramaniam Shanmugam

7

1 reference

Europe PubMed Central

1 November 2017

Judith Sebolt-Leopold

8

1 reference

Europe PubMed Central

1 November 2017

C Max Schmidt

9

1 reference

Europe PubMed Central

1 November 2017

publication date

30 November 2007

1 reference

Europe PubMed Central

1 November 2017

Journal of Gastrointestinal Surgery

1 reference

Europe PubMed Central

1 November 2017

12

1 reference

Europe PubMed Central

1 November 2017

2

1 reference

Europe PubMed Central

1 November 2017

288-296

1 reference

Europe PubMed Central

1 November 2017

https://scigraph.springernature.com/pub.10.1007/s11605-007-0406-6

0 references

Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreaticoduodenectomy: a 20-year experience in 516 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemopreventive and therapeutic effects of curcumin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of NF-kappa B subunits in human pancreatic cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent activation of AKT2 kinase in human pancreatic carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of tumor cell motility by ERK mitogen-activated protein kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PI-3' kinase and NF-kappaB cross-signaling in human pancreatic cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modern management of pancreatic carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1alpha enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NF-kB in development and progression of human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18049840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11605-007-0406-6

1 reference

Europe PubMed Central

1 November 2017

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42521987&oldid=1960538719"